¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"dose conversion factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acceptable daily dose
ÀÏÀÏÇã¿ë·®
average dose
1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
air dose
°ø±â¼±·®
absorbed dose
Èí¼ö¼±·®
absorbed dose rate
Èí¼ö¼±·®·ü
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
booster dose
1. Ãß°¡¿ë·® 2. Ãß°¡Á¢Á¾·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
committed dose equivalent
¿¹Å¹¼±·®ÇØ´ç·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
cumulative dose
1. ´©Àû¿ë·® 2. ´©Àû¼±·®
curative dose
1. Ä¡À¯¿ë·® 2. Ä¡À¯¼±·®
depth dose
½ÉºÎ¼±·®
depth dose curve
½ÉºÎ¼±·®°î¼±
dose
1. ¿ë·®, Åõ¿©·® 2. ¼±·®, Á¶»ç·®
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
dose-response relationship
¿ë·®¹ÝÀÀ°ü°è
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
internal conversion
³»ºÎº¯È¯
lysogenic conversion
¿ë¿øÀüȯ
phage conversion
ÆÄÁöÀüȯ, ÆÄÁö±³È¯
positive conversion
¾çÀü
direct conversion x-ray detector
Á÷Á¢Àüȯ¿¢½º¼±°ËÃâ±â, Á÷Á¢º¯È¯¿¢½º¼±°ËÃâ±â
egg negative conversion rate
Ãæ¶õÀ½ÀüÀ²
absorbed dose
Èí¼ö¼±·®
absorbed dose rate
Èí¼ö¼±·®·ü
acceptable daily dose
ÀÏÀÏÇã¿ë·®
air dose
°ø±â¼±·®
average dose
Æò±Õ¿ë·®, Æò±Õ¼±·®
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
booster dose
Ãß°¡Á¢Á¾·®, Ãß°¡¿ë·®
collective effective dose
Áý´ÜÀ¯È¿¼±·®
collective equivalent dose
Áý´Ü´ç·®¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ED=ÊÝeffective dose
À¯È¿·®.
ID50 (50% infectious dose)
50% °¨¿°·®
LD = lethal dose
Ä¡»ç·®.
LD50 (50% lethal dose)
50% Ä¡»ç·®
LD= lethal dose
Ä¡»ç·®.
MED => minimum effective dose
ÃÖ¼ÒÈ«¹Ý·®
MED=> minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MED=£¾minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MTD=> maximum toderance dose
ÃÖ´ë³»¿ë·®.
MTD=£¾maximum tolerance dose
ÃÖ´ë³»¿ë·®.
MTD=ÊÝmaximum toderance dose
ÃÖ´ë³»¿ë·®.
STD= standard test dose
Ç¥ÁؽÃÇè·®.
absorbed dose
Èí¼ö·®.¹æ»ç¼±Èí¼ö¼±·®(ýåâ¥àÊåÖ).
absorbed dose
Èí¼ö¼±·®
absorbed dose rate
Èí¼ö¼±·®À²
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
conversion
Àüȯ(ï®üµ).
conversion disorder
ÀüȯÀå¾Ö(ï®üµî¡äô)., Àüȯº´
conversion heat
Àüȯ¿(ï®üµæð).
conversion neurosis
Àüȯ½Å°æÁõ(ï®üµ ãêÌèñø)., Àüȯ½Å°æº´
conversion rate
ÀüȯÀ²(ï®üµëÒ).
conversion rate
ÀüȯÀ²(ËøÌ·Ëô).
conversion reaction
Àüȯ¹ÝÀÀ(ï®üµÚãëë).
conversion voice disorder
ÀüȯÀ½¼ºÀå¾Ö
conversion, lysogenic
¿ë¿ø¼ºÀüȯ
conversion, phage
ÆÄÁöÀüȯ
digital scan conversion
¼ýÀÚ ½ºÄµ º¯È¯ (ܨüµ)
digital scan conversion
µðÁöÅÐ ½ºÄµ º¯È¯
direct conversion x-ray detector
Á÷Á¢ º¯È¯ X¼± °ËÃâ±â
gene conversion
À¯ÀüÀÚº¯È¯(ܨüµ).
gene conversion
À¯ÀüÀÚÀüȯ.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½